In addition to erythroleukemia, the aberrantly deregulated FLI1 is also associated with other hematological malignancies, including pre-T cell lymphoblastic lymphoma, acute myeloid leukemia, and B cell lymphomas [1]. This evidence concerns the gene FLI1 and hematologic disorder.